A detailed history of Steward Partners Investment Advisory, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 149,127 shares of BMY stock, worth $8.61 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
149,127
Previous 98,600 51.24%
Holding current value
$8.61 Million
Previous $4.09 Million 88.5%
% of portfolio
0.07%
Previous 0.04%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $2 Million - $2.61 Million
50,527 Added 51.24%
149,127 $7.72 Million
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $269,997 - $355,456
-6,708 Reduced 6.37%
98,600 $4.09 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $436,234 - $494,604
9,092 Added 9.45%
105,308 $5.71 Million
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $344,741 - $411,371
-7,111 Reduced 6.88%
96,216 $4.94 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $2.81 Million - $3.15 Million
-48,616 Reduced 32.0%
103,327 $6 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $140,034 - $155,486
2,198 Added 1.47%
151,943 $9.72 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $1.44 Million - $1.63 Million
-21,893 Reduced 12.76%
149,745 $10.4 Million
Q4 2022

Feb 15, 2023

SELL
$68.48 - $81.09 $513,257 - $607,769
-7,495 Reduced 4.18%
171,638 $12.3 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $7,672 - $4.53 Million
59,018 Added 49.13%
179,133 $12.7 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $448,936 - $494,436
-6,182 Reduced 4.89%
120,115 $9.25 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $6,762 - $8,109
-110 Reduced 0.09%
126,297 $9.22 Million
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $5.46 Million - $6.37 Million
-101,811 Reduced 44.61%
126,407 $7.88 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $3.64 Million - $4.26 Million
61,483 Added 36.87%
228,218 $13.5 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $2.21 Million - $2.4 Million
-35,645 Reduced 17.61%
166,735 $11.1 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $1.59 Million - $1.79 Million
26,825 Added 15.28%
202,380 $12.8 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $518,851 - $587,953
-8,986 Reduced 4.87%
175,555 $10.9 Million
Q3 2020

Oct 30, 2020

BUY
$57.43 - $63.64 $1.24 Million - $1.37 Million
21,595 Added 13.25%
184,541 $11.1 Million
Q2 2020

Aug 06, 2020

BUY
$54.82 - $64.09 $959,514 - $1.12 Million
17,503 Added 12.03%
162,946 $9.58 Million
Q1 2020

Apr 29, 2020

BUY
$46.4 - $67.43 $84,726 - $123,127
1,826 Added 1.27%
145,443 $8.11 Million
Q4 2019

Jan 17, 2020

BUY
$49.21 - $64.19 $1.22 Million - $1.6 Million
24,860 Added 20.93%
143,617 $9.22 Million
Q3 2019

Oct 30, 2019

BUY
$42.77 - $50.71 $40,503 - $48,022
947 Added 0.8%
118,757 $6.02 Million
Q2 2019

Jul 25, 2019

BUY
$44.62 - $49.34 $2.98 Million - $3.3 Million
66,834 Added 131.11%
117,810 $5.34 Million
Q1 2019

Apr 30, 2019

BUY
$45.12 - $53.8 $37,359 - $44,546
828 Added 1.65%
50,976 $2.43 Million
Q4 2018

Jan 15, 2019

SELL
$48.76 - $63.23 $5,656 - $7,334
-116 Reduced 0.23%
50,148 $2.61 Million
Q3 2018

Oct 23, 2018

BUY
$55.19 - $62.25 $391,462 - $441,539
7,093 Added 16.43%
50,264 $3.12 Million
Q2 2018

Jul 20, 2018

BUY
$50.53 - $62.98 $58,665 - $73,119
1,161 Added 2.76%
43,171 $2.39 Million
Q1 2018

Apr 20, 2018

SELL
$59.92 - $68.98 $153,934 - $177,209
-2,569 Reduced 5.76%
42,010 $2.66 Million
Q4 2017

Jan 19, 2018

BUY
$59.94 - $65.35 $273,865 - $298,584
4,569 Added 11.42%
44,579 $2.73 Million
Q3 2017

Nov 22, 2017

BUY
$55.23 - $63.74 $412,844 - $476,456
7,475 Added 22.98%
40,010 $2.55 Million
Q2 2017

Nov 22, 2017

BUY
N/A
12,610 Added 63.29%
32,535 $1.81 Million
Q1 2017

Nov 22, 2017

BUY
N/A
5,189 Added 35.21%
19,925 $1.08 Million
Q4 2016

Nov 22, 2017

BUY
N/A
14,736
14,736 $861,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.